Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-04-006457
Filing Date
2004-05-03
Accepted
2004-05-03 16:36:51
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K d14945a1e10vkza.htm 10-K/A 462558
2 CONSENT OF ERNST & YOUNG LLP d14945a1exv23w1.htm EX-23.1 1386
3 CERTIFICATION OF PRESIDENT AND CEO - SECTION 302 d14945a1exv31w1.htm EX-31.1 3967
4 CERTIFICATION OF VP AND CFO - SECTION 302 d14945a1exv31w2.htm EX-31.2 3972
5 CERTIFICATION OF PRESIDENT AND CEO - SECTION 906 d14945a1exv32w1.htm EX-32.1 3307
6 CERTIFICATION OF VP AND CFO - SECTION 906 d14945a1exv32w2.htm EX-32.2 3539
  Complete submission text file 0000950134-04-006457.txt   480988
Mailing Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229
Business Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229 210-949-8200
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-22147 | Film No.: 04773987
SIC: 2836 Biological Products, (No Diagnostic Substances)